Updated (10:31 a.m.): Updated with Tuesday morning price information.
NEW YORK (TheStreet) -- Jefferies increased its price target on Allergan (AGN) to $139, increased its estimates and set a "hold" rating. The firm noted double digit growth with productive R&D and superior execution.
The stock was up nearly 16% to $164.60 at 10:31 a.m. on Tuesday.
Must Read: Warren Buffett's 10 Favorite Growth StocksSTOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more. STOCKS TO BUY: TheStreet's Stocks Under $10 has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts